Natixis’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Natixis’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-99,000	Closed	-$2.11M	–	1185
2024 Q1	$2.11M	Buy	+99,000	New	+$1.18M	0.01%	435

Natixis's FUSN Position: Q2 2024 in Review

Natixis sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 99,000 shares — an estimated $2.11M sold.

Natixis first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $2.11M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Natixis reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Natixis sold 99,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $2.11M.
Natixis first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Natixis's Fusion Pharmaceuticals Inc. Common Shares position peaked at $2.11M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Natixis's 13F filing for Q2 2024, filed 13 Aug 2024.